Fitxers
Embargament
Document embargat fins el 2027-01-19Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/231085
Characteristics of Colonoscopy- and Fecal Immunochemical Test-Based Screen-Detected Premalignant Neoplastic Lesions: Results From the COLONPREV Study
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Evidence from several studies have shown that colorectal cancer (CRC) screening is effective and cost-effective in average-risk individuals. The most
common screening strategies are fecal immunochemical test (FIT) and
colonoscopy. Whereas the former is predominantly implemented in Europe and Australia, the latter is the dominant screening modality in the US.
.
We have recently published the long-term results of COLONPREV study, the first randomized controlled trial comparing colonoscopy and FIT head-tohead, demonstrating that individuals invited to FIT were more likely to participate
in screening than those invited to colonoscopy. More importantly, FIT-based
screening program appeared not to be inferior to one based on primary
colonoscopy in terms of CRC-related mortality and CRC incidence.
Matèries
Matèries (anglès)
Citació
Citació
CASTELLS GARANGOU, Antoni, et al. Characteristics of Colonoscopy- and Fecal Immunochemical Test-Based Screen-Detected Premalignant Neoplastic Lesions: Results From the COLONPREV Study . Gastroenterology. 2026. Vol. 170, num. 3, pags. 627-630. ISSN 0016-5085. [consulted: 14 of August of 2026]. Available at: https://hdl.handle.net/2445/231085